Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
4. Fcpr Biodiscovery currently holds 2,957,461 shares of Axonics Modulation Technologies, Inc. (AXNX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, 4. Fcpr Biodiscovery has been a net seller of AXNX stock. They have purchased $0 and sold $15.7M worth of shares.
4. Fcpr Biodiscovery's most recent insider trade was on Jan 22, 2020, when they sold 135,261 shares at $31.54 per share.
4. Fcpr Biodiscovery serves as Executive at Axonics Modulation Technologies, Inc. (AXNX). They have executed 3 insider transactions totaling $15.7M over their tenure at the company.
4. Fcpr Biodiscovery holds the position of Executive at Axonics Modulation Technologies, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
4. Fcpr Biodiscovery has shown a selling trading pattern, with $0 in total purchases and $15.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by 4. Fcpr Biodiscovery was on Nov 22, 2019, when they sold $6.2M worth of AXNX shares. This transaction involved 300,000 shares at $20.74 per share.
4. Fcpr Biodiscovery currently owns 2,957,461 shares of Axonics Modulation Technologies, Inc. (AXNX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of 4. Fcpr Biodiscovery's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. 4. Fcpr Biodiscovery has 3 Form 4 filings on record as an insider at Axonics Modulation Technologies, Inc..
Set alerts for 4. Fcpr Biodiscovery and 40,000+ other insiders.